These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 18717723)

  • 1. Cytokine IL-1 beta but not IL-1 alpha promoter polymorphism is associated with Alzheimer disease in a population from the Canary Islands, Spain.
    Déniz-Naranjo MC; Muñoz-Fernandez C; Alemany-Rodríguez MJ; Pérez-Vieitez MC; Aladro-Benito Y; Irurita-Latasa J; Sánchez-García F
    Eur J Neurol; 2008 Oct; 15(10):1080-4. PubMed ID: 18717723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-1alpha and -1beta promoter polymorphisms in Taiwanese patients with dementia.
    Wang HK; Hsu WC; Fung HC; Lin JC; Hsu HP; Wu YR; Hsu Y; Hu FJ; Lee-Chen GJ; Chen CM
    Dement Geriatr Cogn Disord; 2007; 24(2):104-10. PubMed ID: 17622713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin 6-174 G/C promoter gene polymorphism and sporadic Alzheimer's disease: geographic allele and genotype variations in Europe.
    Capurso C; Solfrizzi V; D'Introno A; Colacicco AM; Capurso SA; Capurso A; Panza F
    Exp Gerontol; 2004 Oct; 39(10):1567-73. PubMed ID: 15501028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin 6-174 G/C promoter and variable number of tandem repeats (VNTR) gene polymorphisms in sporadic Alzheimer's disease.
    Capurso C; Solfrizzi V; Colacicco AM; D'Introno A; Frisardi V; Imbimbo BP; Lorusso M; Vendemiale G; Denitto M; Santamato A; Seripa D; Pilotto A; Fiore P; Capurso A; Panza F
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):177-82. PubMed ID: 19897004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Gender has a strong modulating effect on the risk of Alzheimer's disease conferred by the apolipoprotein E gene in the population of the Canary Islands, Spain].
    Déniz Naranjo MC; Muñoz Fernández C; Alemany Rodríguez MJ; Pérez Viéitez MC; Irurita Latasa J; Suárez Armas R; Suárez Valentín MP; Sánchez García F
    Rev Neurol; 2004 Apr 1-15; 38(7):615-8. PubMed ID: 15098180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allele, genotype, and composite genotype effects of IL-1A +4845 and IL-1B +3954 polymorphisms for chronic periodontitis in an Indian population.
    Gayathri R; Saadi AV; Bhat KM; Bhat SG; Satyamoorthy K
    Indian J Dent Res; 2011; 22(4):612. PubMed ID: 22124068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-1 gene -511 CT polymorphism and the risk of Alzheimer's disease in a Polish population.
    Klimkowicz-Mrowiec A; Marona M; Wołkow P; Maruszak A; Styczynska M; Barcikowska M; Zekanowski C; Szczudlik A; Slowik A
    Dement Geriatr Cogn Disord; 2009; 28(5):461-4. PubMed ID: 19940477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study on the polymorphism of interleukin-1 gene and the susceptibility to essential hypertension].
    Li Y; Xu P; Zhang PA; Li XY; Huang CX
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Oct; 21(5):491-3. PubMed ID: 15476179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An association study of inflammatory cytokine gene polymorphisms in Fabry disease.
    Safyan R; Whybra C; Beck M; Elstein D; Altarescu G
    Eur Cytokine Netw; 2006 Dec; 17(4):271-5. PubMed ID: 17353161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-18 promoter polymorphisms and risk of late onset Alzheimer's disease.
    Yu JT; Tan L; Song JH; Sun YP; Chen W; Miao D; Tian Y
    Brain Res; 2009 Feb; 1253():169-75. PubMed ID: 19073159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An interleukin-6 promoter variant is not associated with an increased risk for Alzheimer's disease.
    Depboylu C; Lohmüller F; Gocke P; Du Y; Zimmer R; Gasser T; Klockgether T; Dodel RC
    Dement Geriatr Cogn Disord; 2004; 17(3):170-3. PubMed ID: 14739540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphism 174 G/C of interleukin 6 gene in Alzheimer's disease--preliminary report.
    Paradowski B; Celczyńska D; Dobosz T; Noga L
    Neurol Neurochir Pol; 2008; 42(4):312-5. PubMed ID: 18975235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of association between IL-1β, TNF-α, and IL-10 gene polymorphisms and sporadic Parkinson's disease in an Italian cohort.
    Pascale E; Passarelli E; Purcaro C; Vestri AR; Fakeri A; Guglielmi R; Passarelli F; Meco G
    Acta Neurol Scand; 2011 Sep; 124(3):176-81. PubMed ID: 20880267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. APOE promoter polymorphisms do not confer independent risk for Alzheimer's disease in a French population.
    Zurutuza L; Verpillat P; Raux G; Hannequin D; Puel M; Belliard S; Michon A; Pothin Y; Camuzat A; Penet C; Martin C; Brice A; Campion D; Clerget-Darpoux F; Frebourg T
    Eur J Hum Genet; 2000 Sep; 8(9):713-6. PubMed ID: 10980578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association between promoter polymorphism of the interleukin-10 gene and Alzheimer's disease.
    Ma SL; Tang NL; Lam LC; Chiu HF
    Neurobiol Aging; 2005 Jul; 26(7):1005-10. PubMed ID: 15748779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD14 receptor polymorphism and Alzheimer's disease risk.
    Combarros O; Infante J; Rodríguez E; Llorca J; Peña N; Fernández-Viadero C; Berciano J
    Neurosci Lett; 2005 May 20-27; 380(1-2):193-6. PubMed ID: 15854776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of IL10 promoter polymorphism in Italian Alzheimer's disease.
    Bagnoli S; Cellini E; Tedde A; Nacmias B; Piacentini S; Bessi V; Bracco L; Sorbi S
    Neurosci Lett; 2007 May; 418(3):262-5. PubMed ID: 17420099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-10 and interleukin-6 gene polymorphisms as risk factors for Alzheimer's disease.
    Arosio B; Trabattoni D; Galimberti L; Bucciarelli P; Fasano F; Calabresi C; Cazzullo CL; Vergani C; Annoni G; Clerici M
    Neurobiol Aging; 2004 Sep; 25(8):1009-15. PubMed ID: 15212825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of IL-6 polymorphism on risk of Alzheimer disease: genotype-phenotype association study in Japanese cases.
    Shibata N; Ohnuma T; Takahashi T; Baba H; Ishizuka T; Ohtsuka M; Ueki A; Nagao M; Arai H
    Am J Med Genet; 2002 May; 114(4):436-9. PubMed ID: 11992567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of the APOE-491A/T promoter polymorphism on apolipoprotein E levels and risk of Alzheimer disease: The Rotterdam Study.
    Roks G; Cruts M; Houwing-Duistermaat JJ; Dermaut B; Serneels S; Havekes LM; Hofman A; Breteler MM; Van Broeckhoven C; van Duijn CM
    Am J Med Genet; 2002 Jul; 114(5):570-3. PubMed ID: 12116196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.